Key result
Type 2 diabetes without the atherogenic metabolic triad does not predict angiographic CAD in women.
Why the study?
The coronary heart disease risk of type 2 diabetes is heterogeneous and influenced by the presence or absence of the atherogenic metabolic triad, but its impact on angiographically assessed CAD in women was unclear.
Does the presence of the atherogenic metabolic triad affect the risk of angiographically assessed coronary artery disease in women with type 2 diabetes compared to nondiabetic women?
Cross-Sectional (n=250)
Does the presence of the atherogenic metabolic triad affect the risk of angiographically assessed coronary artery disease in women with type 2 diabetes compared to nondiabetic women?
This study investigates whether the atherogenic metabolic triad is a necessary factor for type 2 diabetes to predict angiographically assessed coronary artery disease in women.
Does not support diabetes alone for CAD risk assessment in women without the triad; leaves open metabolic factors' role in sex-specific prediction.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Blackburn et al. (2007) conducted a cross-sectional in Coronary artery disease (n=250). Type 2 diabetes with or without the atherogenic metabolic triad vs. Nondiabetic women was evaluated on Coronary artery disease (CAD) assessed by angiography. Type 2 diabetes without the atherogenic metabolic triad did not predict angiographically assessed coronary artery disease in women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: